New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
11:02 EDTCRK, NTE, PRAN, MAR, ATIHigh option volume stocks: CRK NTE PRAN MAR ATI
News For CRK;NTE;PRAN;MAR;ATI From The Last 14 Days
Check below for free stories on CRK;NTE;PRAN;MAR;ATI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
10:44 EDTMARMarriott sees North America RevPAR higher in Q3 than Q4
Subscribe for More Information
10:23 EDTMARMarriott says group demand 'looking very good'
Subscribe for More Information
July 29, 2014
16:49 EDTMARMarriott sees FY14 EPS $2.40-$2.51, consensus $2.47
Subscribe for More Information
16:47 EDTMARMarriott sees Q3 EPS 59c-63c, consensus 61c
Subscribe for More Information
16:45 EDTMARMarriott reports Q2 adjusted EPS 71c, consensus 67c
Reports Q2 revenue $3.48B, consensus $3.53B. Reports Q2 North American comparable systemwide RevPAR rose 6.0% with average daily rates up 3.7%. On a constant dollar basis, worldwide comparable systemwide RevPAR rose 5.8% in Q2, including a 3.5% increase in average daily rate
15:53 EDTMARNotable companies reporting after market close
Subscribe for More Information
July 22, 2014
07:37 EDTATIAllegheny Technologies expects Q3 business conditions to improve
Subscribe for More Information
07:31 EDTATIAllegheny Technologies reports Q2 EPS (3c), consensus 1c
Reports Q2 revenue $1.12B, consensus $1.06B.
July 17, 2014
16:27 EDTPRANPrana updates Alzheimer disease development program
Prana Biotechnology has provided an update on its clinical development program for Alzheimer's disease. In Professor Colin Masters' July presentation, which includes data from Prana's phase 2 IMAGINE and EURO trials, he noted that the starting amyloid burden level in the PBT2 treated participant group had an important bearing on the decrease of amyloid over time in that participant, whereas there was no such correlation in the placebo group. Separately, Prana has confirmed the top line finding that there is a very promising trend towards the preservation of brain volume in PBT2 treated patients compared to placebo patients.
11:00 EDTPRANHigh option volume stocks
High option volume stocks: OMC FXC TSEM JRJC MAT MTG PRAN SEAS BURL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use